Showing results (141-150 of 2,745) with videos related to
Sort By:
Pageof 275
Neurologia I Neurochirurgia Polska|September 1, 1985
[Drug-induced dyskinesia during the treatment of Parkinson disease--biochemical studies]A FriedmanEuropean Journal of Pharmacology|November 26, 1985
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatumM Traub, H R Wagner, M Hassan, et al.Peptides|January 1, 1983
Neurotensin interacts with dopaminergic neurons in rat brainA Reches, R E Burke, D Jiang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiencyJ G de Yebenes, S Fahn, V Jackson-Lewis, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1989
Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonusD D Truong, M P Galloway, G Pezzoli, et al.Neurology|August 1, 1990
Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollisP Greene, U Kang, S Fahn, et al.The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.Neurologia I Neurochirurgia Polska|January 1, 1978
[Preliminary assessment of the effectiveness of L-dopa with prolonged action (Medidopa retard) as compared to conventional L-dopa preparation]A FriedmanPharmacology, Biochemistry, and Behavior|April 1, 1989
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in ratsR Stennett, M Katz, V Jackson-Lewis, et al.Pageof 275